Glutamine With Topical Corticosteroids for Lichen Planus Treatment

• Status: Completed
• Trial end date: 2020-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Glutamine promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hams Hamed Abdelrahman
• Treatments: Miconazole

Criteria

Inclusion Criteria:

1. Patients clinically and histopathologically diagnosed to be suffering from EOLP.

2. Patients who had symptoms i.e. pain and/or burning sensation secondary to EOLP.

3. Patients under stressful life conditions as evidenced by ISMA-UK Stress Questionnaire

4. Males and Females with an age ranging from 30-60years

Exclusion Criteria:

1. Patients suspected to have a lichenoid drug reaction or lichenoid contact allergy.

2. Patients suffering from any systemic diseases (such as diabetes, cardiovascular, liver disorder, renal dysfunction)

3. Patients with findings of any physical or mental abnormality which would interfere with or be affected by the study procedure.